Transcript
Dr. Chris Callewart (0:00)
Hi.
Sarah Gibson Tuttle (0:00)
Who here loves when their nails are perfectly done?
Dr. Samantha Youmeen (0:04)
Me.
Sarah Gibson Tuttle (0:04)
I'm Sarah Gibson Tuttle and I started Olive in June because let's be real, we all deserve to have gorgeous nails. But who wants to spend a fortune or half their day at the salon? And that's why I created the mani system. So you can have that salon perfect manicure right at home. And guess what? The best part, each mani only costs $2. Yup, you heard me. $2. No more 30, 40, $50 salon trips that eat up your day. Now you can paint your whenever you want, wherever you want. And trust me, you're gonna be obsessed with your nails and everyone is gonna ask you where did you get your nails done? And here's a little something extra. Head over to oliveandjune.com and get 20% off your first mani system with code perfectmani20@oliveandjune.com perfectmanny20. That's code perfectmanny20 for 20% off@oliveandjeune.com perfectmanny2 0. You're all set for a nail glow up. Let's get those nails looking fabulous, shall we?
Jerry Insurance / Blissey Ads Voice (0:59)
Most drivers overpay for car insurance, not because they're careless, but because the system is needlessly complicated. Jerry fixes that. Traditional comparison sites give you quotes once, then disappear. But Jerry can handle all the insurance shopping, legwork and never stops working. Compare 50 plus insurers side by side and purchase directly in the app. No spam calls, no hidden fees. They'll even monitor price trends and can alert you to better rates. Drivers who save with Jerry could save over $1,300 a year. Download the Jerry app or visit Jerry AI Acast today.
Kim Holderness (1:33)
This episode is brought to you by Peloton. The new Cross Training series balances your workouts with more than 15 workout types for endless movements on and off your equipment. Stay motivated with weekly personalized plans that guide you from beginner to expert and push you past your goals with routines tailored to you. Get the new Cross Training series Terms apply.
Dr. Samantha Youmeen (1:55)
Foreign. Welcome back. We've got an exciting lineup this episode. First up, we'll discuss a recent clinical trial for a patch that could improve the lives of the many people living with peanut allergies if it gets approved. And then later, we'll explore a surprising theory. Did a volcanic eruption play a role in the spread of the Black Death? And finally, as someone who's currently experimenting with my personal scent, I am very excited about the guest who will be joining me later. Prepare for a unique conversation with none other than Dr. Armpit, we're going to discuss an often ignored but never unnoticed topic, body odor. I'm Dr. Smith Youmeen and this is Curiosity Weekly. Chances are you know someone who has a peanut allergy. Well, there's some encouraging news on the horizon. In December 2025, DBV Technologies shared the successful results of its Phase 3 trial for the Vascan peanut allergy patch. Now this is a comeback for the company considering they faced a pretty tough setback five years ago when the FDA initially rejected the patch. The trial involved 654 children between the ages of four and seven, making it one of the largest studies for peanut allergy immunotherapy. Remarkably, nearly half of those with the Viascan patch could tolerate peanuts after 12 months. That's compared to only about 15% in the placebo group. It doesn't mean they got rid of the allergy. What they actually measured was how much more peanut exposure the body could handle. But the difference in tolerance is encouraging. It could mean less of a risk if you have an accidental exposure. In case you're wondering what happened the last time around, let's quickly revisit some history. The Vascan patch was initially rejected back in 2020 because the FDA said it needed some modifications so that it would stick better to the skin. And they also called for more supporting data. And that wasn't even their first attempt. They had previously withdrawn their application in 2018 and since then they've pressed on. And now with the success of their latest trial, they're gearing up to submit a new application to the FDA in early 20, aiming for priority review. Peanut allergies are a significant public health concern, affecting like 1 to 2% of the U.S. population. And the rates have been rising over the past few decades, especially among children. Living with a peanut allergy can be super challenging because even small amounts of peanuts can trigger severe life threatening reactions. And peanuts seem to be present in a lot of pre packed foods, especially snacks and treats. Ice cream, granola bars, some breads, salad dressing, cereals, and even birdseed and beauty products can be processed in facilities with peanuts. Peanuts. Families managing this allergy have to be vigilant in everyday situations and social settings. Grappling with potential emergencies, social stigma and reading labels and all of that can take a heavy emotional toll on someone. So having a patch that helps desensitize the immune system could be life changing. The Vascan patch works by delivering a small amount of peanut antigen through the skin, effectively retraining the immune system to tolerate peanuts. While most side effects were mild. Some of the study participants experienced skin reactions and two of them had treatment related anaphylaxis. Encouragingly, both of them continued with the therapy and there were no serious adverse events due to the treatment. There's still a way to go, but in the meantime, I'll be keeping an eye on all of the exciting new research in this field because any breakthrough could mean a lot for the families navigating peanut allergies. Here's to hoping for a future filled with more tasty snacks and fewer worries.
